RaySearch Laboratories AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	284.77	287.8	262.9	110.09	32.38	-58.67
Other Adjustments	228.79	241	247.6	284.46	282.29	244.29
Change in Receivables	-89.92	-71.4	-23.9	31.78	-66.04	17.05
Changes in Other Operating Activities	-74.56	-70.4	-1.4	29.61	72.03	35.5
Operating Cash Flow	349.08	387	485.2	455.93	320.66	238.16
Operating Cash Flow Growth	-24.89%	-20.24%	6.42%	42.19%	34.64%	-28.16%
Capital Expenditures	-27.91	-28.1	-13.3	-24.3	-13.4	-51.97
Purchases of Intangible Assets	-205.74	-200	-204.3	-185.04	-187.99	-203.25
Other Investing Activities	-	-	-	-	-	17.59
Investing Cash Flow	-233.55	-228.1	-217.5	-209.33	-201.38	-237.63
Short-Term Debt Issued	-	-	-	-	-21.27	21.27
Net Short-Term Debt Issued (Repaid)	-	-	-	-	-21.27	21.27
Long-Term Debt Repaid	-76.83	-76.7	-91.2	-56.35	-51.22	-93.5
Net Long-Term Debt Issued (Repaid)	-76.83	-76.7	-91.2	-56.35	-51.22	-93.5
Common Dividends Paid	-102.85	-102.8	-68.6	-	-	-
Financing Cash Flow	-179.67	-179.6	-159.8	-56.35	-72.49	-72.23
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.07	-34.8	11.2	-6.84	10.95	5.49
Net Cash Flow	-64.14	-20.7	107.9	190.25	46.78	-71.7
Free Cash Flow	321.17	358.9	471.9	431.64	307.26	186.19
Free Cash Flow Growth	-10.51%	-23.95%	9.33%	40.48%	65.03%	-38.31%
FCF Margin	-	26.70%	39.59%	-	-	-
Free Cash Flow Per Share	9.37	10.47	13.76	12.59	8.96	5.43
Levered Free Cash Flow	-179.3	52.6	97.6	-51.04	-13.86	-88.71
Unlevered Free Cash Flow	-102.47	132.86	186.94	5.31	58.64	-16.47